Literature DB >> 6221842

B cell activation by pokeweed mitogen in cultures of normal peripheral blood lymphocytes depleted of T regulator subsets by treatment with OKT4 and OKT8 monoclonal antibodies.

B M Jones.   

Abstract

OKT4+ (T helper/inducer) and OKT8+ (T cytotoxic/suppressor) subsets were depleted from peripheral blood lymphocytes (PBL) by complement-mediated lysis and residual cells examined for responsiveness to pokeweed mitogen (PWM) using a protein A haemolytic plaque assay for immunoglobulin secreting B cells. It was shown that: (1) three cycles of cell killing were required to totally abolish T helper function; (2) OKT4- PBL did not respond to PWM, but in a co-culture system, an equal number of unfractionated normal PBL could entirely reconstitute responsiveness of the residual B cells; (3) OKT8- PBL gave enhanced numbers of PWM-induced plaque forming cells (PFC); (4) addition of 4 micrograms/ml concanavalin A (con A) to PWM stimulated OKT8- PBL failed to suppress PFC generation, but suppression was induced by 12.5 and 25 micrograms/ml con A and (5) kinetics of PWM-induced PFC development were similar in the presence or absence of OKT8+ cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6221842      PMCID: PMC1536783     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Concanavalin A-activated suppressor cells in normal human peripheral blood lymphocytes.

Authors:  C Hubert; G Delespesse; A Govaerts
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

2.  Functional assessment of a B cell defect in patients with selective IgA deficiency.

Authors:  J T Cassidy; G Oldham; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

3.  Activation of human B lymphocytes. III. Concanavalin A-induced generation of suppressor cells of the plaque-forming cell response of normal human B lymphocytes.

Authors:  B F Haynes; A S Fauci
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

4.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

5.  Suppressor activity of T lymphocytes from infants assessed by co-culture with unfractionated adult lymphocytes in the pokeweed mitogen system.

Authors:  T Miyawaki; H Seki; M Kubo; N Taniguchi
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

6.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

7.  Cell-mediated immune response in vitro. II. The mechanism(s) involved in the suppression of the development of cytotoxic lymphocytes.

Authors:  T Hirano; A A Nordin
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

8.  T cell helper defect in patients with chronic lymphocytic leukemia.

Authors:  N Chiorazzi; S M Fu; G Montazeri; H G Kunkel; K Rai; T Gee
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

9.  Use of a human plaque-forming cell assay to study peripheral blood bursa-equivalent cell activation and excessive suppressor cell activity in humoral immunodeficiency.

Authors:  H G Herrod; R H Buckley
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

10.  Heterogeneity of concanavalin A-induced suppressor T cells in man defined with monoclonal antibodies.

Authors:  N K Damle; S Gupta
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

View more
  6 in total

1.  In vivo and in vitro studies into the immunological changes following iodine 131 therapy for Graves' disease.

Authors:  R Wilson; J H McKillop; C Jenkins; J A Thomson
Journal:  Eur J Nucl Med       Date:  1991

2.  B lymphocyte activation by insoluble anti-mu antibodies in patients with systemic lupus erythematosus.

Authors:  H Becker; U Schauer; K Helmke
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

3.  The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus.

Authors:  P S Mach; M Kharouby; F Lutcher; J L Olivier; N Bazely; M Dougados; B Amor
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

4.  In vitro anti-acetylcholine receptor antibody synthesis by myasthenia gravis patient lymphocytes: correlations with thymic histology and thymic epithelial-cell interactions.

Authors:  D Safar; S Berrih-Aknin; E Morel
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

5.  The in vitro production and regulation of anti-double stranded DNA antibodies by peripheral blood mononuclear cells from normals and patients with systemic lupus erythematosus.

Authors:  P S Mach; M Kharouby; F Lutcher; J L Olivier; N Bazely; M Dougados; B Amor
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

6.  Differential Response of B Cells to an Immunogen, a Mitogen and a Chemical Carcinogen in a Mouse Model System

Authors:  Nimisha Saxena; Amar Preet Kaur; Nimai Chand Chandra
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.